1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients
(
- Contribution to journal › Article
- 2020
-
Mark
Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset Breast Cancer : A Population-Based Study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Increased cancer risk in families with pediatric cancer is associated with gender, age, diagnosis, and degree of relation to the child
2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(11). p.2171-2179(
- Contribution to journal › Article
- 2018
-
Mark
Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
(
- Contribution to journal › Article
- 2012
-
Mark
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2007
-
Mark
A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families
(
- Contribution to journal › Article
- 2004
-
Mark
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations : results of a prospective study in Southern Sweden
(
- Contribution to journal › Article
- 2000
-
Mark
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
(
- Contribution to journal › Article
- 1999
-
Mark
CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
(
- Contribution to journal › Article